Clinical Trials Sponsored by Arjo France

Total 5624 results

Arjo France
Pôle Saint Hélier

Recruiting

Evaluation of the Sub Epidermal Moisture a Device for the Screening of Pressure Ulcer (RELIASEM) (RELIASEM)

Preventive Care

France
Arjo AB
Loughborough University

Enrolling by invitation

A Comparison Study of the Maxi Move 5 (MM5) Device

Healthy Volunteers

United Kingdom
Arno Therapeutics

Unknown

Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer

Recurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Androgen-independent Prostate Cancer

United Kingdom
Arno Therapeutics

Unknown

Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers

Progesterone Receptor Positive Tumor: Max 1 Line of Prior Chemotherapy, no Prior Hormone Therapy

France
Arno Therapeutics

Unknown

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Glioblastoma Multiforme | Gliosarcoma | GBM

United States, Canada
Arno Therapeutics

Unknown

Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome

United States
Arno Therapeutics

Completed

Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma

Lymphoma | Solid Tumors

United States, United Kingdom
Argo Sante
GenSight Biologics

Completed

Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection

Leber's Hereditary Optic Neuropathy (LHON)

France
Aro Biotherapeutics

Recruiting

Study to Assess the Safety, Tolerability, PK and PD of ABX1100

Healthy

Canada
ARO Medical

Unknown

Safety Study of ARO Spinal System as an Adjunct to Lumbar Decompression

Lumbar Disc Prolapse With Radiculopathy

Denmark
University of Kentucky
Arno Therapeutics

Completed

A Phase I Study of AR-67 (7-t-butyldimethylsilyl-10-hydroxycamptothecin) Given on Days 1, 4 8, 12 & 15 of an Every 21-day Cycle in Adult Patients With Refractory or Metastatic Solid Malignancies

Solid Malignancies

United States
ARJ Medical, Inc.

Recruiting

PyloPlus Urea Breath Test System Post Therapy Efficacy Confirmation Study

Helicobacter Pylori Infection | Efficacy | Post-Treatment

United States
ARJ Medical, Inc.

Recruiting

PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study

Efficacy | Safety | Helicobacter Pylori

United States
ARJ Medical, Inc.

Completed

ARJ C13 Urea Breath Test System

H. Pylori Infection

United States
Xention Ltd
Ario Pharma Ltd

Completed

A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With Chronic Idiopathic Cough

Chronic Idiopathic Cough

United Kingdom, Ireland
Xention Ltd
Ario Pharma Ltd

Completed

A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With COPD

Chronic Obstructive Pulmonary Disease

United Kingdom
Arno Schmidt-Trucksäss

Recruiting

Heart Rate Variability, Physical Activity and Exhaustion in the Inpatient Treatment of Stress-Related Disorders (HARMODI)

Depression | Burnout | Stress Related Disorder

Switzerland
Arno Schmidt-Trucksäss

Recruiting

Sequelae of COVID-19 With Focus on Exercise Capacity and Underlying Mechanisms (COR-PHYS)

Controls | Patients Post-COVID-19

Switzerland
Eli Lilly and Company
ARMO BioSciences

Terminated

Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer (Cypress 1)

Non Small Cell Lung Cancer

United States
Eli Lilly and Company
ARMO BioSciences

Completed

Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer (Sequoia)

Pancreatic Cancer

United States, Belgium, Spain, Poland, Korea, Republic of, Taiwan, Germany, Italy, France, United Kingdom, Austria, Australia, Canada
Eli Lilly and Company
ARMO BioSciences

Completed

A 3-Way Crossover Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518) (Willow 2)

Healthy Adult Subjects

United States
University of Copenhagen
Anjo A/S

Completed

Milk Types and Fish Oil in 9- to 12-Month-Old Infants

Obesity | Cardiovascular Disease | Metabolic Syndrome | Growth | Blood Pressure
Eli Lilly and Company
ARMO BioSciences

Active, not recruiting

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors (IVY)

Melanoma | Renal Cell Carcinoma | Breast Cancer | Ovarian Cancer | Prostate Cancer | Non-small Cell Lung Carcinoma | Solid Tumors | Colorectal Carcinoma | Pancreatic Carcinoma

United States
Arno Schmidt-Trucksäss

Completed

Mini-trampoline Intervention vs. Nordic Walking: Balance, Fitness and Neuropsychological Effects (TraWaFit)

Obesity | Overweight

Switzerland
University Hospital Inselspital, Berne
Arco Foundation

Completed

Effect of Transcutaneous Electrostimulation (TENS) on Pain and Physical Function in Patients With Knee Osteoarthritis (ETRELKA)

Osteoarthritis, Knee

Switzerland
Eremo Hospital, Arco
University of Padova

Completed

Robot-assisted Rehabilitation of the Upper Limb in Acute and Subacute Post-stroke Patients

Stroke | Cerebrovascular Accident | Upper Extremity Paresis

Italy
Central Hospital, Nancy, France
French Cardiology Society

Completed

Relationship Between Thoracic Aortic Structure Assessed B PET/CT Scan and Arterial Stiffness in Elderly Patients (FICTEP)

Inflammation | Aging

France
University Hospital, Strasbourg, France
Sanofi; French State

Unknown

Thromboprophylaxis and Bariatric Surgery

Thromboembolism

France
Eli Lilly and Company
ARMO BioSciences

Terminated

Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer (Cypress 2)

Non Small Cell Lung Cancer

United States
Arno Schmidt-Trucksäss

Completed

The COmPLETE Study (COmPLETE)

Heart Failure | Aging

Switzerland
Eli Lilly and Company
ARMO BioSciences

No longer available

An Expanded Access Program for AM0010 (Pegilodecakin)

Melanoma | Renal Cell Carcinoma | Breast Cancer | Ovarian Cancer | Prostate Cancer | Non-small Cell Lung Carcinoma | Solid Tumors | Colorectal Carcinoma | Pancreatic Carcinoma
Eli Lilly and Company
ARMO BioSciences

Completed

A Crossover Study to Evaluate Pegilodecakin (LY3500518) in Healthy Participants (Willow 3)

Healthy

United States
Eli Lilly and Company
ARMO BioSciences

Completed

A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518) (Willow 1)

Healthy Adult Subjects

United States
Fondazione Edmund Mach
Casa di Cura Eremo di Arco (TN) Italy; OlioCRU Consorzio srl Arco (TN) Italy

Completed

Measuring the Impact of Dietary Supplementation With a New Baking Product on Gut Microbiota and Cholesterol Metabolism

Hypercholesterolemia

Italy
Central Hospital, Nancy, France
Ministry of Health, France; Boehringer Ingelheim; French Cardiology Society

Completed

Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Population (PARTAGE)

Hypertension | Cognitive Impairment | Elderly | Morbidity | Cardiovascular Mortality

France, Italy
Prof. Dr. med. Arno Frigg

Recruiting

Evaluation of the Effect of Biofeedback on Osseous Union Using Pedobarography After Mid- and Hindfoot Arthrodesis

Complication of Surgical or Medical Care

Switzerland
Action, France

Recruiting

Registry of Coronary Artery Ill Patients With Platelet Test Results (ONASSIST)

Myocardial Infarction | Acute Coronary Syndrome | Percutaneous Coronary Intervention

France
STEBA France

Completed

Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure

Prostate Cancer

Canada
Stragen France

Completed

First-In-Human PainCart Study for STR-324

Pain

Netherlands
Biotronik France

Unknown

BIOTRONIK - BIOFLOW-III Registry French Satellite

Coronary Artery Diseases

France
Hexacath, France

Unknown

Comparative Phase IV Study: Efficacy And Safety of TiTAN2 Versus COBALT-CHROME Stents- EVIDENCEII (EVIDENCE II)

Acute Coronary Syndrome | Stable Angina | Silent Myocardial Infarction

France
Candela France

Completed

Evaluation of Fractional Bipolar Radiofrequency for the Treatment of Striae

Striae

France
Vitatron France

Unknown

Arrhythmia Restart Prevention and RatE STabilization in Atrial Fibrillation

Sick Sinus Syndrome | Brady-Tachy Syndrome

France
Medtrum France

Completed

MEDTRUM A7+ TouchCare Insulin Patch Pump (MedInPS) (MedInPS)

Diabetes Mellitus

France
Action, France

Unknown

Biological Collection and Registry of Patients Who Will Have a TAVR (Transcatheter Aortic Valve Replacement) Intervention (BIO TAVI)

Transcatheter Aortic Valve Replacement

France
Brahms France

Terminated

Study of Procalcitonin (PCT)-Guided Antibiotic Use in Severe Sepsis Patients Without Obvious Infection (Pro-SEPS)

Severe Sepsis

France
STEBA France

Terminated

Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy

Prostate Cancer

Canada
STEBA France

Suspended

Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis

Esophagitis, Reflux

Canada
Central Hospital, Nancy, France
Central Hospital, Reims, France; Central Hospital, Toulouse, France; Central... and other collaborators

Unknown

New Insulin Therapy by Multiwave Bolus (EVANEWFIT2)

Type1diabetes

France
French Cardiology Society
Agence Regionale de Sante d'Ile de France

Terminated

SAFEty and Efficacy of HOME-based Hospitalization Versus Inpatient Care for Patients With Acute Heart Failure in Chronic Heart Failure. (SAFE-HOME)

Heart Failure

France

Clinical Trials Sponsored by Arjo France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations